Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

1.

Economic evaluation of screening for disease.

Praditsitthikorn N.

J Med Assoc Thai. 2014 May;97 Suppl 5:S94-101.

PMID:
24964705
[PubMed - indexed for MEDLINE]
2.

Cost-utility analysis of treatments for stage IB cervical cancer.

Katanyoo K, Praditsitthikorn N, Tangjitgamol S, Manusirivithaya S, Supawattanabodee B.

J Gynecol Oncol. 2014 Apr;25(2):97-104. doi: 10.3802/jgo.2014.25.2.97. Epub 2014 Apr 9.

PMID:
24761212
[PubMed]
Free PMC Article
3.

A cost-utility analysis of alternative drug regimens for newly diagnosed severe lupus nephritis patients in Thailand.

Mohara A, Pérez Velasco R, Praditsitthikorn N, Avihingsanon Y, Teerawattananon Y.

Rheumatology (Oxford). 2014 Jan;53(1):138-44. doi: 10.1093/rheumatology/ket304. Epub 2013 Oct 4.

PMID:
24097289
[PubMed - indexed for MEDLINE]
4.

Assessing key model parameters for economic evaluation of pandemic influenza interventions: the data source matters.

Praditsitthikorn N, Kotirum S, Mohara A, Dumrongprat K, Velasco RP, Teerawattananon Y.

Influenza Other Respir Viruses. 2013 Sep;7 Suppl 2:59-63. doi: 10.1111/irv.12091.

PMID:
24034486
[PubMed - indexed for MEDLINE]
5.

Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand.

Rattanavipapong W, Koopitakkajorn T, Praditsitthikorn N, Mahasirimongkol S, Teerawattananon Y.

Epilepsia. 2013 Sep;54(9):1628-38. doi: 10.1111/epi.12325. Epub 2013 Jul 29.

PMID:
23895569
[PubMed - indexed for MEDLINE]
6.

Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics.

Pérez Velasco R, Praditsitthikorn N, Wichmann K, Mohara A, Kotirum S, Tantivess S, Vallenas C, Harmanci H, Teerawattananon Y.

PLoS One. 2012;7(2):e30333. doi: 10.1371/journal.pone.0030333. Epub 2012 Feb 29. Review.

PMID:
22393352
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.

Praditsitthikorn N, Teerawattananon Y, Tantivess S, Limwattananon S, Riewpaiboon A, Chichareon S, Ieumwananonthachai N, Tangcharoensathien V.

Pharmacoeconomics. 2011 Sep;29(9):781-806. doi: 10.2165/11586560-000000000-00000.

PMID:
21838332
[PubMed - indexed for MEDLINE]
8.

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.

Jit M, Demarteau N, Elbasha E, Ginsberg G, Kim J, Praditsitthikorn N, Sinanovic E, Hutubessy R.

BMC Med. 2011 May 12;9:54. doi: 10.1186/1741-7015-9-54.

PMID:
21569406
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A determination of topics for health technology assessment in Thailand: making decision makers involved.

Lertpitakpong C, Chaikledkaew U, Thavorncharoensap M, Tantivess S, Praditsitthikorn N, Youngkong S, Yothasamut J, Udomsuk K, Sinthitichai K, Teerawattananon Y.

J Med Assoc Thai. 2008 Jun;91 Suppl 2:S100-9.

PMID:
19253492
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk